Formulation and method for relieving or preventing symptoms associated with uric acid crystals

a technology of uric acid crystals and forms, applied in the direction of biocide, animal repellents, drug compositions, etc., can solve the problems of nausea, vomiting, diarrhea, significant adverse side effects, etc., and achieve the effect of relieving or preventing symptoms

Inactive Publication Date: 2009-10-29
TRUSCOTT KENT J +1
View PDF5 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These medications are effective, but have significant adverse side-effects.
While colchicine is effective, it often causes nausea, vomiting and diarrhea.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0038]The following three dietary supplements were purchased at iHerb:[0039]Natural Factors, Celery Seed Extract, 60 Capsules for $11.97. Each capsule contained 75 mg celery (Apium graveolens) seed extract (standardized to contain 85% 3-n-butylphthalide calculated as total phthalides)[0040]Enzymatic Therapy, Cherry Fruit Extract, 180 Capsules for $20.27. Each capsule contained 500 mg of sweet cherry (Prunus avium) fruit extract, in a 10:1 concentrate by weight.[0041]Nutrient Carriers Incorporated, Advanced Research, Lithium Orotate, 120 mg, 200 Tablets for $15.00 Each tablet contained 4.9 mg elemental lithium.

[0042]A 54 year old man weighing approximately 300 lbs, who was experiencing recurring episodes of gout approximately every few months, was selected for treatment. This man was not known to be taking any other medications at the time of treatment. During one severe episode of gout, the following treatment was provided, and was continued for several months:[0043]1 capsule of cel...

example 2

[0045]A 51 year old man weighing approximately 155 lbs, who experienced gout symptoms occasionally (approximately once or twice a year) was selected for treatment. This man was known to be taking multiple food supplements, including 3 gm of Vitamin C and multiple herbs with anti-inflammatory properties, but he was still getting occasional gout symptoms. During one episode of gout pain and inflammation, the following treatment was provided:[0046]4 capsules of celery seed extract—two taken twice per day,[0047]5 capsules of cherry fruit extract—two taken in the morning, one at lunch, and two in the evening, and[0048]3 tablets of lithium orotate—one taken three times a day.

During the first four days of treatment the man in addition took ½ tablet of 0.6 mg colchicine twice a day and massaged the big toe joint with Three Angels Liniment from Blue Poppy Herbs three to four times per day. All the gout symptoms were gone by three days after the initiation of treatment. After four additional ...

example 3

[0050]16 capsules of celery seed extract, 20 capsules of cherry fruit extract, and 12 tablets of lithium orotate are emptied and mixed together in a mortar and pestle. All of the resulting homogeneously mixed powder is placed evenly into 12 empty size 000 gelatin capsules, with no additional filler. Each gelatin capsule thus contains 100 mg celery seed extract, approx. 833 mg cherry fruit extract, and 4.9 mg lithium as lithium orotate.

[0051]A patient with gout takes the capsules, 1 capsule with each of 3 meals per day, for two to four days, until all gout symptoms are abated. No NSAIDS nor colchicine are taken during this time, so there is no gastrointestinal distress as a result of the treatment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
wt %aaaaaaaaaa
weightaaaaaaaaaa
weightaaaaaaaaaa
Login to view more

Abstract

A method for relieving or preventing symptoms associated with uric acid crystals, comprising consuming a formulation that supports three or more processes, the processes comprising:1) one that inhibits formation of uric acid in the body;2) one that increases elimination of uric acid from the body; and3) one that interferes with formation of uric acid crystals in the body.A formulation, comprising: an extract of celery; an extract of cherry; and a lithium salt. Also, a process to make a formulation, comprising mixing together:i. a material that inhibits formation of uric acid in a body;ii. a material that increases elimination of uric acid from the body;iii. a material that interferes with formation of uric acid crystals in the body; and forming the mixture into a medicament.

Description

FIELD OF THE INVENTION[0001]This invention is directed to a method for relieving or preventing symptoms associated with uric acid crystals, a formulation for relieving or preventing symptoms associated with uric acid crystals, a process to make the formulation, and the formulation made by the process.BACKGROUND OF THE INVENTION[0002]Uric acid is an end product of nitrogen metabolism in the human body (the main product being urea), and is found in small amounts in blood and urine. The disease ‘gout’ in humans is associated with abnormally high levels of uric acid in the blood and in the urinary system and with the formation of uric acid crystals in or near the joints. The symptoms caused by uric acid crystals include redness, swelling, inflammation, pain, kidney stones, and reduced movement. Increased concentration of uric acid in the human blood stream may also result in one form of kidney stones when the uric acid crystallizes into a solid inside the kidney. The uric acid crystals ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K36/736A61P13/12
CPCA61K33/00A61K36/23A61K36/736A61K2300/00A61K31/513A61P13/04A61P13/12A61P19/06A61P43/00A61K9/0053A61K9/20A61K9/48
Inventor TRUSCOTT, KENT J.ABERNATHY, SUSAN M.
Owner TRUSCOTT KENT J
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap